What is CAI study?

The CAI study is a federally funded study on study to determine the efficacy of CAI. The study is funded by the National Cancer Institute of National Institute of Health under Award Number R01CA203719. The study will be conducted from 09/20/2022 to 08/31/2027

What is the purpose of this study?

The purpose of this study is to further develop CAPA with additional components for ABD and the individual optimization functionality (CAI) and to test the efficacy of CAI in improving cancer pain experience of ABD.

What are the long terms goals of this study?

The long-term goals are to: (a) to extend and test CAI in various healthcare settings with diverse subgroups of ABD, (b) examine the cost-effectiveness, sustainability, and scalability of CAI in the settings, and (c) translate CAI into health care for ABD.

How can I contact the research team for further information?

If you have any questions or need more information, please contact the research team at cai.help@austin.utexas.edu.